TW225525B - - Google Patents

Info

Publication number
TW225525B
TW225525B TW081104646A TW81104646A TW225525B TW 225525 B TW225525 B TW 225525B TW 081104646 A TW081104646 A TW 081104646A TW 81104646 A TW81104646 A TW 81104646A TW 225525 B TW225525 B TW 225525B
Authority
TW
Taiwan
Prior art keywords
formula
image
compounds
converted
derivative
Prior art date
Application number
TW081104646A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of TW225525B publication Critical patent/TW225525B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
TW081104646A 1991-11-23 1992-06-15 TW225525B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4138585 1991-11-23

Publications (1)

Publication Number Publication Date
TW225525B true TW225525B (zh) 1994-06-21

Family

ID=6445453

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081104646A TW225525B (zh) 1991-11-23 1992-06-15

Country Status (9)

Country Link
US (1) US5359067A (zh)
EP (1) EP0544210B1 (zh)
JP (1) JP3261181B2 (zh)
KR (1) KR100273823B1 (zh)
AT (1) ATE186300T1 (zh)
CA (1) CA2083436C (zh)
DE (1) DE59209762D1 (zh)
DK (1) DK0544210T3 (zh)
TW (1) TW225525B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6792700A (en) * 1999-08-20 2001-03-19 Research Foundation Of The State University Of New York, The 5-propynylpyrimidine derivatives as cytotoxic enzyme inhibitors
CN1302004C (zh) * 2003-08-22 2007-02-28 浙江海正药业股份有限公司 一种阿糖胞苷的制备方法
JP7413362B2 (ja) 2019-03-29 2024-01-15 シスメックス株式会社 新規人工核酸、その製造方法及び用途
WO2020226889A1 (en) * 2019-05-07 2020-11-12 Wellstat Therapeutics Corporation Formulations of uridine triacetate in triacetin
WO2022065413A1 (ja) 2020-09-25 2022-03-31 株式会社理研ジェネシス 新規人工核酸、その製造方法及び用途
WO2023127857A1 (ja) 2021-12-27 2023-07-06 株式会社理研ジェネシス 新規人工核酸、その製造方法及び用途

Also Published As

Publication number Publication date
JPH05222034A (ja) 1993-08-31
DK0544210T3 (da) 2000-04-25
EP0544210B1 (de) 1999-11-03
ATE186300T1 (de) 1999-11-15
CA2083436A1 (en) 1993-05-24
KR930010007A (ko) 1993-06-21
EP0544210A1 (de) 1993-06-02
CA2083436C (en) 2004-05-11
KR100273823B1 (ko) 2000-12-15
US5359067A (en) 1994-10-25
DE59209762D1 (de) 1999-12-09
JP3261181B2 (ja) 2002-02-25

Similar Documents

Publication Publication Date Title
HU9301361D0 (en) Method for producing 4-aryl-piperazines and 4-aryl-piperidines
AU4755393A (en) Azaquinoxalines, processes for their preparation and their use
AU559154B2 (en) Substituted dibenzoylmethanes as sunscreen agents
GR3007513T3 (zh)
TW232013B (zh)
TW225525B (zh)
ZA9339B (en) 4,13-dioxabicyclo(8.2.1)tridecenone derivatives, process and intermediates for the preparation thereof and pharmaceuticals containing these compounds
BG97916A (en) Phenylbenzamide fungicides and method for obtaining them
AU533087B2 (en) Agents for regulating plant growth
IL100541A0 (en) Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
PL296165A1 (en) Method of obtaining diastereoselective reducing pinacolic coupling of homochiral -aminoaldehydes
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
NO940018D0 (no) Fremgangsmaate for fremstilling av svovelholdige imidazolderivater
IL116169A (en) Free radical initiated process for the preparation of alkyl halodifluoroacetates
AP9600800A0 (en) 2-(Pyrazol-3-yl) carbapenem derivatives.
EP0614908A3 (en) Method of preparation of 3-beta-aminocholanic acid derivatives.
DE3369136D1 (en) Pyrazolidinedione derivative having vasodilating, antiaggregating and hypocholesterolemic activities
GR74782B (zh)
ZA822988B (en) 5-(4-phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1h-imidazole-4-carboxylic acid derivatives
HUT62851A (en) Process for the diastereoselective reductive pinacol coupling of homochiral alpha-aminoaldehydes
IN170286B (zh)
CA1262546C (zh)
EP0342482A3 (en) Process for the preparation of pyrimidine derivatives
ES2103166A1 (es) Procedimiento para la obtencion de amidinohidrazonas biciclicas.
GR3004684T3 (zh)